PHILADELPHIA--(BUSINESS WIRE)--Feb. 16, 2007--At the
AmerisourceBergen Corporation (NYSE:ABC) annual meeting of
stockholders, held today in Philadelphia, Company stockholders
re-elected three directors: Edward E. Hagenlocker, Kurt J. Hilzinger,
and Henry W. McGee. In addition, stockholders ratified the appointment
of Ernst & Young as the Company's independent registered public
accounting firm for fiscal 2007. During the meeting,
AmerisourceBergen's Chief Executive Officer, R. David Yost, gave an
overview of the Company's activities and outlook for the coming year.
Mr. Hagenlocker, 67, has been a director of the Company since
August 2001. Prior to that, he was a director of AmeriSource Health
Corporation from 1999 to August 2001. He was Vice Chairman of Ford
Motor Company from 1996 until his retirement in 1999 and Chairman of
Visteon Automotive Systems from 1997 to 1999. Mr. Hagenlocker is also
a director of Air Products and Chemicals, Inc., American Standard
Companies Inc. and Alcatel-Lucent.
Mr. Hilzinger, 46, has been a director of the Company since March
2004, and has been President and Chief Operating Officer of the
Company since October 2002. Prior to that, he was Executive Vice
President and Chief Operating Officer of the Company from August 2001
to October 2002. Mr. Hilzinger was President and Chief Operating
Officer of AmeriSource Health Corporation from December 2000 to August
2001, Senior Vice President and Chief Operating Officer of AmeriSource
Health Corporation from January 1999 to December 2000 and Senior Vice
President and Chief Financial Officer of AmeriSource Health
Corporation from 1997 to January 1999. He is also a director of Humana
Inc.
Mr. McGee, 54, has been a director of the Company since November
2004. He has been President of HBO Video, a unit of Home Box Office,
Inc., since 1995. He held a variety of other positions with Home Box
Office, Inc., Time Warner, Inc. (the parent of Home Box Office, Inc.)
and their predecessors since 1979. Mr. McGee is President of the Alvin
Ailey Dance Foundation, Inc.
The AmerisourceBergen Board of Directors is comprised of ten
members.
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is one of the world's largest
pharmaceutical services companies serving the United States, Canada
and selected global markets. Servicing both pharmaceutical
manufacturers and healthcare providers in the pharmaceutical supply
channel, the Company provides drug distribution and related services
designed to reduce costs and improve patient outcomes.
AmerisourceBergen's service solutions range from pharmacy automation
and pharmaceutical packaging to pharmacy services for skilled nursing
and assisted living facilities, reimbursement and pharmaceutical
consulting services, and physician education. With more than $61
billion in annual revenue, AmerisourceBergen is headquartered in
Valley Forge, PA, and employs more than 14,000 people.
AmerisourceBergen is ranked #27 on the Fortune 500 list. For more
information, go to www.amerisourcebergen.com.
FORWARD-LOOKING STATEMENTS
This news release may contain certain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements
are based on management's current expectations and are subject to
uncertainty and changes in circumstances. Actual results may vary
materially from the expectations contained in the forward-looking
statements. The following factors, among others, could cause actual
results to differ materially from those described in any
forward-looking statements: competitive pressures; the loss of one or
more key customer or supplier relationships; customer defaults or
insolvencies; changes in customer mix; supplier defaults or
insolvencies; changes in pharmaceutical manufacturers' pricing and
distribution policies or practices; adverse resolution of any contract
or other disputes with customers (including departments and agencies
of the U.S. Government) or suppliers; regulatory changes (including
increased government regulation of the pharmaceutical supply channel);
changes in U.S. government policies (including reimbursement changes
arising from federal legislation, including the Medicare Modernization
Act and the Deficit Reduction Act of 2005); price inflation in branded
pharmaceuticals and price deflation in generics; declines in the
amounts of market share rebates offered by pharmaceutical
manufacturers to the PharMerica Long-Term Care business, declines in
the amounts of rebates that the PharMerica Long-Term Care business can
retain, and/or the inability of the business to offset the rebate
reductions that have already occurred or any rebate reductions that
may occur in the future; any disruption to or other adverse effects
upon the PharMerica Long-Term Care business caused by the announcement
of the Company's agreement to combine the PharMerica Long-Term Care
business with the institutional pharmacy business of Kindred
Healthcare, Inc. into a new public company that will be owned 50% by
the Company's shareholders (the "PharMerica LTC Transaction"); the
inability of the Company to successfully complete the PharMerica LTC
Transaction; fluctuations in market interest rates; operational or
control issues arising from the Company's outsourcing of information
technology activities; success of integration, restructuring or
systems initiatives; fluctuations in the U.S. dollar - Canadian dollar
exchange rate and other foreign exchange rates; economic, business,
competitive and/or regulatory developments in Canada, the United
Kingdom and elsewhere outside of the United States; acquisition of
businesses that do not perform as we expect or that are difficult for
us to integrate or control; changes in tax legislation or adverse
resolution of challenges to our tax positions; and other economic,
business, competitive, legal, tax, regulatory and/or operational
factors affecting the business of the Company generally. Certain
additional factors that management believes could cause actual
outcomes and results to differ materially from those described in
forward-looking statements are set forth (i) in Item 1A (Risk Factors)
in the Company's Annual Report on Form 10-K for the fiscal year ended
September 30, 2006 and elsewhere in that report and (ii) in other
reports filed by the Company pursuant to the Securities Exchange Act
of 1934.
CONTACT: AmerisourceBergen Corporation
Michael N. Kilpatric, 610-727-7118
mkilpatric@amerisourcebergen.com
SOURCE: AmerisourceBergen Corporation